1. TLR4 mediates high-fat diet induced physiological changes in mice via attenuating PPARγ/ABCG1 signaling pathway.
- Author
-
Cao XJ, Zhang MJ, Zhang LL, Yu K, Xiang Y, Ding X, Fan J, Li JC, and Wang QS
- Subjects
- Animals, Enzyme-Linked Immunosorbent Assay, Inflammation pathology, Lipids chemistry, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Muscle, Smooth, Vascular pathology, Signal Transduction, Toll-Like Receptor 4 deficiency, ATP Binding Cassette Transporter, Subfamily G, Member 1 metabolism, Diet, High-Fat adverse effects, Inflammation metabolism, Muscle, Smooth, Vascular metabolism, PPAR gamma metabolism, Toll-Like Receptor 4 metabolism
- Abstract
High-fat diet (HFD) is known to promote atherosclerosis which accelerates the development of atherosclerotic cardiovascular diseases. Vascular dysfunction characterized by inflammation and lipid accumulation is common in atherosclerosis caused by HFD. The specific effects of HFD on blood vessels and the underlying mechanisms need to be further clarified. Toll-like receptor 4 (TLR4) is a key contributing factor in atherosclerosis and TLR4 deficiency protects vascular smooth muscle cells against inflammatory responses and lipid accumulation in vitro. However, the physiological significance of TLR4 signaling in HFD-induced changes is unknown. In this study, we observed that HFD feeding increased body weight, circulating inflammatory cytokines and lipid accumulation in the aorta of wild-type mice but apart from increasing body weight, did not affect the TLR4 knockout mice. TLR4 expression increased significantly in the arterial walls after receiving HFD treatment, while that of the co-localizing PPARγ and ABCG1 markedly decreased. TLR4 deficiency reversed the HFD-induced attenuation of PPARγ and ABCG1. In conclusion, TLR4 mediates HFD induced increase in body weight, inflammation and aortic lipid accumulation through, at least partly, the PPARγ/ABCG1 signaling pathway. Therefore, interfering with TLR4 signaling is a viable therapeutic option in diet induced atherosclerosis., (Copyright © 2018 Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF